Calumet Historical Balance Sheet
CLMT Stock | USD 20.78 1.05 4.81% |
Trend analysis of Calumet Specialty Products balance sheet accounts such as Property Plant And Equipment Net of 934.6 M, Non Current Assets Total of 1.2 B or Non Currrent Assets Other of 141.1 M provides information on Calumet Specialty's total assets, liabilities, and equity, which is the actual value of Calumet Specialty to its prevalent stockholders. By breaking down trends over time using Calumet Specialty balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Calumet Specialty latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Calumet Specialty is a good buy for the upcoming year.
Calumet Specialty Inventory |
|
Calumet |
About Calumet Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Calumet Specialty at a specified time, usually calculated after every quarter, six months, or one year. Calumet Specialty Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Calumet Specialty and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Calumet currently owns. An asset can also be divided into two categories, current and non-current.
Calumet Specialty Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Calumet Specialty assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Calumet Specialty books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Most accounts from Calumet Specialty's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Calumet Specialty current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Calumet Specialty Products. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At this time, Calumet Specialty's Deferred Long Term Liabilities is comparatively stable compared to the past year.
2021 | 2022 | 2023 | 2024 (projected) | Accounts Payable | 301M | 442M | 322M | 239.3M | Total Current Liabilities | 899.8M | 1.4B | 1.1B | 1.2B |
Calumet Specialty balance sheet Correlations
Click cells to compare fundamentals
Calumet Specialty Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Calumet Specialty balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.9B | 1.8B | 2.1B | 2.7B | 2.8B | 1.8B | |
Total Stockholder Equity | (10.6M) | (12.3M) | (10.1M) | (287.7M) | (491.6M) | (467.0M) | |
Property Plant And Equipment Net | 1.1B | 1.0B | 1.1B | 1.6B | 1.6B | 934.6M | |
Non Current Assets Total | 1.3B | 1.3B | 1.5B | 1.9B | 2.0B | 1.2B | |
Non Currrent Assets Other | 36.5M | 37.2M | 169.1M | 122.6M | 134.4M | 141.1M | |
Other Assets | 36.5M | 37.2M | 169.1M | 122.6M | 110.3M | 59.0M | |
Common Stock Shares Outstanding | 78.2M | 78.4M | 79.0M | 79.3M | 80.1M | 52.4M | |
Liabilities And Stockholders Equity | 1.8B | 1.9B | 2.5B | 2.7B | 2.8B | 1.8B | |
Other Stockholder Equity | (20.2M) | 125.3M | 378.8M | (279.4M) | (484.4M) | (460.2M) | |
Total Liab | 1.8B | 1.9B | 2.5B | 3.0B | 3.0B | 1.5B | |
Property Plant And Equipment Gross | 1.1B | 1.0B | 1.1B | 1.6B | 2.7B | 2.9B | |
Other Current Liab | 192.9M | 212.6M | 341.7M | 587.3M | 645.9M | 678.2M | |
Total Current Liabilities | 565M | 544.5M | 899.8M | 1.4B | 1.1B | 1.2B | |
Accounts Payable | 230.2M | 179.3M | 301M | 442M | 322M | 239.3M | |
Other Liab | 28.7M | 28.2M | 101.3M | 100.6M | 115.7M | 121.5M | |
Cash | 19.1M | 109.4M | 38.1M | 35.2M | 7.9M | 7.5M | |
Long Term Debt | 1.2B | 1.3B | 1.4B | 1.5B | 1.8B | 1.1B | |
Inventory | 292.6M | 254.9M | 326.6M | 498M | 439.4M | 324.2M | |
Intangible Assets | 71.2M | 57.6M | 45.8M | 36.3M | 28.5M | 27.1M | |
Property Plant Equipment | 973.5M | 919.8M | 1.1B | 1.5B | 1.7B | 960.9M | |
Short Long Term Debt Total | 1.3B | 1.4B | 1.6B | 1.7B | 2.2B | 1.2B | |
Current Deferred Revenue | 79.5M | 68.8M | 333.1M | 190.4M | 219.0M | 229.9M | |
Net Debt | 1.3B | 1.3B | 1.5B | 1.6B | 2.0B | 1.1B | |
Cash And Short Term Investments | 19.1M | 109.4M | 38.1M | 35.2M | 7.9M | 7.5M | |
Net Receivables | 188.5M | 160.4M | 253M | 244.7M | 286.2M | 218.0M | |
Non Current Liabilities Total | 1.3B | 1.4B | 1.6B | 1.7B | 1.9B | 1.2B | |
Total Current Assets | 512.1M | 534.9M | 632.6M | 820.4M | 794.7M | 650.2M | |
Accumulated Other Comprehensive Income | (7.2M) | (8.7M) | (10.6M) | (12.3M) | (10.1M) | (6.8M) | |
Short Term Debt | 62.4M | 143.1M | 245.5M | 312.1M | 131.3M | 75.3M | |
Net Tangible Assets | (221M) | (359.2M) | (607.7M) | (497M) | (447.3M) | (424.9M) | |
Long Term Debt Total | 1.2B | 1.3B | 1.4B | 1.5B | 1.8B | 1.5B | |
Deferred Long Term Liab | 31.7M | 34.2M | 82.3M | 119.7M | 137.7M | 144.5M | |
Non Current Liabilities Other | 61.7M | 73M | 15.8M | 137.7M | 10.4M | 9.9M | |
Common Stock | 20.2M | (125.3M) | (378.8M) | (529.9M) | (476.9M) | (453.1M) | |
Short Long Term Debt | 1.5M | 2.3M | 7.4M | 19.1M | 55.7M | 36.0M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.